Table 3

Genetic alterations in biliary duct carcinoma

Type of carcinoma
Genetic alterationsPolypoid (n=12)Non-polypoid
infiltrative (n=22)
Total (n=34)
LOH
 5q8/11 (73%)3-150 5/19  (26%)3-150 13/30  (43%)
 9p5/8 (63%)10/17 (59%)15/25 (60%)
 17p6/11 (55%)7/14 (50%)13/25 (52%)
 18q1/5 (20%)2/11 (18%)3/16 (19%)
K-ras mutation3/12 (25%)6/22 (27%)9/34 (26%)
  • LOH, loss of heterozygosity.

  • 3-150 p<0.05.